There was a 49 percent spike in the number of tech
IPO pipeline companies headquartered in New York than there were last year.
Not exact matches
Health care
companies represent a third of
companies of the 122
companies in the
IPO pipeline, and 60 percent of new filings in August.
Nutanix is one of the high - profile unicorns, or venture - backed tech
companies valued at $ 1 billion or more, that have been waiting in the
IPO pipeline.
There are currently 25
companies in the tech
IPO pipeline that are raising or have raised a financing round at a valuation of $ 1 billion or more, according to the data.
David Ludwig of Goldman Sachs» Investment Banking Division explains that increasing investor confidence and investor willingness to pay more for growth
companies have been key drivers behind an attractive tech
IPO pipeline for 2017.
We've identified 34 digital health
companies on our Tech
IPO pipeline list, alongside 6 digital health
companies valued above a billion dollars (Zocdoc, Proteus Digital Health, 23andMe, NantHealth, Oscar, and GuaHao), many of which will need to go to public markets for further funding if late - stage investors continue to move further away from private markets as they did in Q4 ’15 (this may be a trend that's particularly pronounced in healthcare, where
companies have much longer time horizons for returns).
The
IPO market in the US is positioned for a very active fourth quarter, with more than 170
companies in the
pipeline, according to Renaissance Capital, based in Greenwich, Connecticut.
New issues from a number of emerging markets
companies in the second half of 2013, as well as a growing deal
pipeline, indicate that there could be significant growth in
IPOs this year, Bon says.
Biotech
companies that don't have new drugs or therapies in the
pipeline yet (about 40 percent of all those that went public last year, in fact) tend to take advantage of an
IPO window because they have serious cost burdens --- like multiple drug tests and regulatory approval --- that other VC - backed
companies don't have.
Bloomberg reports that Kinder Morgan Energy Partners, the Houston - based
pipeline company taken private three years ago by The Carlyle Group and Goldman Sachs's private equity arm in a $ 22 billion leveraged buyout, is proceeding with plans for an
IPO.
Many of last year's enterprise tech
IPOs performed well, giving
pipeline companies confidence in their debuts.